ConductScience.org, home

Paper79026

Oral vancomycin for antibiotic-associated pseudomembranous colitis.

Tedesco F and 4 others. Lancet, 1978. Cited by 235 papers, by iCite.

Cite this record

ConductScience Library. Oral vancomycin for antibiotic-associated pseudomembranous colitis. Papers, record 79026. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/79026

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Oral vancomycin for antibiotic-associated pseudomembranous colitis.
PubMed
Journal
Lancet
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
235
iCite
Relative citation ratio, by iCite
9.06
iCite
Revised in PubMed
2022-03-31
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tedesco FF
2Markham RR
3Gurwith MM
4Christie DD
5Bartlett JGJ G

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Enterocolitis, PseudomembranousMajor topic
VancomycinMajor topic
Administration, Oral
Ampicillin
Bacterial Toxins
Cefazolin
Clindamycin
Feces
Humans
Penicillins

Source PubMed

Download CSV of topics

Cited by48

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 235 citations.

PMIDTitleJournalYearIn PapersSource
42621893Gut microecology in critical illness: mechanisms, biomarkers, and therapeutic strategies - a critical appraisal.Front Gastroenterol (Lausanne)2026https://conductscience.org/library/papers/42621893PubMed
42103430Redefining Diagnostic and Management Approaches to Vancomycin Adverse Drug Reactions.J Allergy Clin Immunol Pract2026https://conductscience.org/library/papers/42103430PubMed
40639850Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study.J Immunother Cancer2025https://conductscience.org/library/papers/40639850PubMed
39823126Effectiveness of oral vancomycin as prophylaxis against Clostridioides difficile infection in hematopoietic stem cell transplant patients.Antimicrob Steward Healthc Epidemiol2024https://conductscience.org/library/papers/39823126PubMed
36641624Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy.Mol Ther2023https://conductscience.org/library/papers/36641624PubMed
33409109Uncommon Case of Oral Vancomycin Neurotoxicity With Sexual Dysfunction.Cureus2020https://conductscience.org/library/papers/33409109PubMed
32580613Microbe-Derived Butyrate and Its Receptor, Free Fatty Acid Receptor 3, But Not Free Fatty Acid Receptor 2, Mitigate Neointimal Hyperplasia Susceptibility After Arterial Injury.J Am Heart Assoc2020https://conductscience.org/library/papers/32580613PubMed
31713055Does oral vancomycin use necessitate therapeutic drug monitoring?Infection2020https://conductscience.org/library/papers/31713055PubMed
30574127Development of Neutralizing and Non-neutralizing Antibodies Targeting Known and Novel Epitopes of TcdB of Clostridioides difficile.Front Microbiol2018https://conductscience.org/library/papers/30574127PubMed
30057833An Unusual Case of Ototoxicity with Use of Oral Vancomycin.Case Rep Infect Dis2018https://conductscience.org/library/papers/30057833PubMed
29576480Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone Marrow Transplantation in Mice.Cell Host Microbe2018https://conductscience.org/library/papers/29576480PubMed
27877096A Prospective Pilot Study on the Systemic Absorption of Oral Vancomycin in Children With Colitis.J Pediatr Pharmacol Ther2016https://conductscience.org/library/papers/27877096PubMed
25534724Pharmacokinetics of LFF571 and vancomycin in patients with moderate Clostridium difficile infections.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/25534724PubMed
25404529Clostridium difficile infection: guideline-based diagnosis and treatment.Dtsch Arztebl Int2014https://conductscience.org/library/papers/25404529PubMed
24729930Clinical update for the diagnosis and treatment of Clostridium difficile infection.World J Gastrointest Pharmacol Ther2014https://conductscience.org/library/papers/24729930PubMed
23264053MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammation.Infect Immun2013https://conductscience.org/library/papers/23264053PubMed
21502971Treatment of refractory and recurrent Clostridium difficile infection.Nat Rev Gastroenterol Hepatol2011https://conductscience.org/library/papers/21502971PubMed
21192802Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection.BMC Infect Dis2010https://conductscience.org/library/papers/21192802PubMed
15149585Treatment of Clostridium difficile Infection.Curr Treat Options Gastroenterol2004https://conductscience.org/library/papers/15149585PubMed
9258629Drug-induced Clostridium difficile-associated disease.Drug Saf1997https://conductscience.org/library/papers/9258629PubMed

See all 48 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/79026

GET https://conductscience.org/api/papers/v1/79026/cited_by?page=2